-
1 week ago | 
conexiant.com | Susan Heavey |Puyaan Singh
The CDC is still recommending COVID-19 vaccines for healthy children, according to its latest published immunization schedule. The schedule, published late on Thursday by the public health agency, comes after Health and Human Services Secretary Robert F. Kennedy Jr. — alongside the heads of the FDA and the National Institutes of Health — earlier this week said the CDC would stop recommending routine COVID vaccines for healthy children and pregnant women.
-
1 week ago | 
today.westlaw.com | Puyaan Singh |Alan Barona |Susan Heavey |Shounak Dasgupta
(Reuters) -The U.S. Centers for Disease Control and Prevention is still recommending COVID-19 vaccines for healthy children, according to its latest published immunization schedule, contradicting Health and Human Services Secretary Robert F. Kennedy...
-
1 week ago | 
today.westlaw.com | Puyaan Singh
(Reuters) -The U.S. Centers for Medicare & Medicaid Services said on Tuesday it will increase oversight to stop states from using Medicaid dollars to cover healthcare for illegal immigrants. More than 71 million people are covered by Medicaid, a...
-
2 weeks ago | 
zawya.com | Puyaan Singh |Christy Santhosh
U.S. Food and Drug Administration advisers unanimously recommended on Thursday that COVID-19 vaccines for the 2025-26 period should target newer strains of the JN.1 variant. COVID vaccine makers are seeing increased regulatory scrutiny under the new FDA leadership, facing tighter requirements for their shots that could increase expenses.
-
2 weeks ago | 
marketscreener.com | Puyaan Singh |Christy Santhosh
Published on 05/22/2025 at 14:56, updated on 05/23/2025 at 10:55 (Reuters) - U.S. Food and Drug Administration advisers unanimously recommended on Thursday that COVID-19 vaccines for the 2025-26 period should target newer strains of the JN.1 variant. COVID vaccine makers are seeing increased regulatory scrutiny under the new FDA leadership, facing tighter requirements for their shots that could increase expenses.
-
2 weeks ago | 
reuters.com | Christy Santhosh |Puyaan Singh
May 22 (Reuters) - The U.S. Food and Drug Administration's advisory panel is set to vote on Thursday to recommend whether COVID-19 vaccines for the 2025-2026 immunization campaign should target strains of the virus descending from the JN.1 variant. According to the Centers for Disease Control and Prevention, the LP.8.1 strain - a subvariant of the previously recommended JN.1 strain - accounted for 70% of total cases in the U.S. over a two-week period ended May 10. Sign up here.
-
2 weeks ago | 
gazette.com | Puyaan Singh |Christy Santhosh
By Puyaan Singh and Christy Santhosh(Reuters) - U.S. Food and Drug Administration advisers unanimously recommended on Thursday that COVID-19 vaccines for the 2025-26 period should target newer strains of the JN.1 variant. COVID vaccine makers are seeing increased regulatory scrutiny under the new FDA leadership, facing tighter requirements for their shots that could increase expenses.
-
2 weeks ago | 
ca.marketscreener.com | Kamal Choudhury |Puyaan Singh
Published on 2025-05-21 at 05:19, updated on 2025-05-21 at 08:07 (Reuters) -Medical device maker Medtronic said on Wednesday it plans to separate its diabetes business, which houses its insulin pumps and other wearable devices, into a stand-alone company and forecast 2026 adjusted profit below estimates. The unit has been struggling over the last few years following regulatory concerns over quality management and cybersecurity issues related to its certain devices.
-
2 weeks ago | 
marketscreener.com | Kamal Choudhury |Puyaan Singh
Published on 05/21/2025 at 05:19, updated on 05/21/2025 at 12:39 (Reuters) -Medical device maker Medtronic said on Wednesday it plans to separate its diabetes business, which houses its insulin pumps and other wearable devices, into a stand-alone company and forecast 2026 adjusted profit below estimates. The unit has been struggling over the last few years following regulatory concerns over quality management and cybersecurity issues related to its certain devices.
-
2 weeks ago | 
today.westlaw.com | Puyaan Singh |Sriparna Roy |Nivedita Bhattacharjee |Kamal Choudhury
(Reuters) -Medical device maker Medtronic said on Wednesday it plans to separate its diabetes business, which houses its insulin pumps and other wearable devices, into a stand-alone company and forecast 2026 adjusted profit below estimates.
